NASDAQ:TWST - Twist Bioscience Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$20.64 -1.40 (-6.35 %)
(As of 12/16/2018 12:51 PM ET)
Previous Close$20.64
Today's Range$20.4859 - $21.93
52-Week Range$12.38 - $34.46
Volume79,387 shs
Average Volume200,020 shs
Market Capitalization$549.21 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company was founded in 2013 and is headquartered in San Francisco, California.

Receive TWST News and Ratings via Email

Sign-up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TWST
Previous Symbol
CUSIPN/A
Phone408-410-0105

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees221
Outstanding Shares26,610,000
Market Cap$549.21 million
OptionableNot Optionable

Twist Bioscience (NASDAQ:TWST) Frequently Asked Questions

What is Twist Bioscience's stock symbol?

Twist Bioscience trades on the NASDAQ under the ticker symbol "TWST."

When is Twist Bioscience's next earnings date?

Twist Bioscience is scheduled to release their next quarterly earnings announcement on Wednesday, December 19th 2018. View Earnings Estimates for Twist Bioscience.

What price target have analysts set for TWST?

3 analysts have issued 1 year price targets for Twist Bioscience's stock. Their predictions range from $25.99 to $25.99. On average, they expect Twist Bioscience's share price to reach $25.99 in the next twelve months. This suggests a possible upside of 25.9% from the stock's current price. View Analyst Price Targets for Twist Bioscience.

What is the consensus analysts' recommendation for Twist Bioscience?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Twist Bioscience in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Twist Bioscience.

Has Twist Bioscience been receiving favorable news coverage?

Media stories about TWST stock have trended positive recently, according to InfoTrie. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Twist Bioscience earned a media sentiment score of 3.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 8.0 out of 10, indicating that recent media coverage is very likely to have an impact on the stock's share price in the next several days.

Who are some of Twist Bioscience's key competitors?

Who are Twist Bioscience's key executives?

Twist Bioscience's management team includes the folowing people:
  • Dr. Emily Marine Leproust, Co-Founder, Pres, CEO & Director (Age 45)
  • Mr. James M. Thorburn, Chief Financial Officer (Age 62)
  • Mr. Mark Daniels Esq., Gen. Counsel, Sec. and Chief Ethics & Compliance Officer (Age 56)
  • Mr. William Charles Banyai, COO & Director (Age 63)
  • Mr. Bill Peck, Chief Technology Officer (Age 58)

When did Twist Bioscience IPO?

(TWST) raised $75 million in an initial public offering (IPO) on Wednesday, October 31st 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Cowen acted as the underwriters for the IPO and Allen & Company and Baird were co-managers.

When did Twist Bioscience's quiet period expire?

Twist Bioscience's quiet period expired on Monday, December 10th. Twist Bioscience had issued 5,000,000 shares in its initial public offering on October 31st. The total size of the offering was $70,000,000 based on an initial share price of $14.00. During Twist Bioscience's quiet period, underwriters and any insiders involved in the IPO were restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Twist Bioscience?

Shares of TWST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Twist Bioscience's stock price today?

One share of TWST stock can currently be purchased for approximately $20.64.

How big of a company is Twist Bioscience?

Twist Bioscience has a market capitalization of $549.21 million. Twist Bioscience employs 221 workers across the globe.

What is Twist Bioscience's official website?

The official website for Twist Bioscience is http://www.twistbioscience.com.

How can I contact Twist Bioscience?

Twist Bioscience's mailing address is 455 MISSION BAY BOULEVARD SOUTH SUITE 5, SAN FRANCISCO CA, 94158. The company can be reached via phone at 408-410-0105.


MarketBeat Community Rating for Twist Bioscience (NASDAQ TWST)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  15 (Vote Outperform)
Underperform Votes:  17 (Vote Underperform)
Total Votes:  32
MarketBeat's community ratings are surveys of what our community members think about Twist Bioscience and other stocks. Vote "Outperform" if you believe TWST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TWST will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel